Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA complex group 4 pseudogene 3 (HCG4P3; ENSG00000237669) is a pseudogene located within the major histocompatibility complex (HLA) region of chromosome 6. As a pseudogene, it is derived from duplication of an ancestral HLA gene but does not encode a functional protein. The HLA region contains many such pseudogenes resulting from segmental duplications and genetic rearrangements throughout human evolution.[2][3] There is no evidence to support a direct role in immune function, disease, or therapeutic drug targeting. Pseudogenes in the HLA region are of interest primarily for evolutionary study and may, in some rare cases, be transcribed, but do not produce active molecules involved in immunity or other biological processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA complex group 4 pseudogene 3.